Status:
COMPLETED
Hepatitis B Virus Prevalence and Risk Factors in Belgium
Lead Sponsor:
Hasselt University
Conditions:
Hepatitis B
Eligibility:
All Genders
18-70 years
Brief Summary
The aim of this study was to evaluate the current prevalence and risk factors of hepatitis B virus (HBV) infection in a multi-ethnic neighbourhood situated in Middle Limburg, Belgium. Additionally, th...
Detailed Description
Although the HBV prevalence is generally low in Western countries, such as Belgium, pockets of higher HBV prevalence exist in areas with large immigrant populations. Therefore national prevalence figu...
Eligibility Criteria
Inclusion
- Age between 18 and 70
- Males and females
Exclusion
- /
Key Trial Info
Start Date :
May 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 27 2017
Estimated Enrollment :
1131 Patients enrolled
Trial Details
Trial ID
NCT03425513
Start Date
May 12 2017
End Date
November 27 2017
Last Update
January 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600